quasiexperiment
multisit
studi
hospit
commun
academ
within
saint
luke
health
system
kansa
citi
missouri
studi
receiv
investig
review
board
waiver
approv
patient
includ
posit
viru
pcr
pct
valu
ngml
within
hour
least
activ
system
antibiot
autom
emr
best
practic
alert
bpa
patient
implement
decemb
figur
epic
verona
wisconsin
wwwepiccom
alert
fire
upon
provid
open
emr
criteria
met
contain
messag
antimicrobi
stewardship
alert
patient
posit
viral
pcr
neg
procalcitonin
one
antibiot
order
result
suggest
viral
reassess
necess
antibiot
indic
contain
pcr
pct
result
list
activ
antibiot
three
option
proceed
avail
acknowledg
meet
criteria
make
antimicrobi
decis
first
suppress
alert
perman
last
allow
continu
fire
time
emr
open
option
select
electron
time
stamp
allow
assess
provid
respons
alert
fire
time
prospect
bpa
group
includ
patient
alert
fire
decemb
februari
retrospect
compar
group
includ
patient
met
alert
fire
criteria
decemb
march
patient
exclud
year
old
antibiot
also
use
concomit
nonrespiratori
indic
identifi
base
indic
includ
antibiot
order
requir
antimicrobi
order
institut
well
manual
record
review
primari
endpoint
inpati
antibioticday
therapi
defin
individu
antibiot
given
day
calcul
ad
togeth
total
number
day
patient
receiv
individu
antibiot
secondari
endpoint
discontinu
antibiot
within
hour
initi
day
antibiot
alert
fire
reiniti
antibiot
discontinu
clostridioid
difficil
infect
discharg
prescript
rate
day
antibiot
prescrib
discharg
alert
fire
endpoint
retrospect
group
defin
time
point
inform
pct
pcr
antibiot
order
avail
provid
reiniti
antibiot
discontinu
defin
new
antibiot
order
respiratori
indic
antibiot
stop
signific
period
eg
day
serum
pct
level
measur
vida
brahm
durham
north
carolina
clinic
detect
rang
ngml
intern
guidanc
pct
lrti
strongli
discourag
antibiot
use
pct
valu
ngml
discourag
use
ngml
consist
us
food
drug
administr
label
pct
test
lrti
respiratori
pcr
sampl
test
use
filmarray
respiratori
panel
biofir
diagnost
salt
lake
citi
utah
detect
common
respiratori
virus
atyp
bacteria
continu
variabl
shown
mean
standard
deviat
analyz
use
student
test
categor
nomin
variabl
shown
number
compar
use
fisher
exact
test
appropri
multivari
linear
regress
model
develop
assess
independ
associ
prospect
bpa
group
day
therapi
adjust
follow
variabl
base
clinic
judgement
age
ventilatorday
charlson
comorbid
index
respiratori
viral
ill
communityacquir
pneumonia
healthcareassoci
pneumonia
hospitalacquir
pneumonia
ventilatorassoci
pneumonia
chronic
obstruct
pulmonari
diseas
upper
respiratori
infect
rhinoviru
adenoviru
human
metapneumoviru
influenza
influenza
b
respiratori
syncyti
viru
rsv
intens
care
unit
icu
length
stay
twotail
statist
test
util
signific
level
set
p
statist
analysi
complet
use
sa
softwar
sa
institut
cari
north
carolina
two
hundr
twentysix
patient
includ
prospect
bpa
group
retrospect
group
signific
differ
age
sex
race
among
group
tabl
bpa
group
significantli
higher
mean
charlson
comorbid
index
score
vs
p
lower
mean
icu
length
stay
vs
day
p
viral
detect
rate
pcr
vari
group
tabl
influenza
b
common
bpa
group
vs
p
vs
p
respect
rsv
also
common
bpa
group
vs
p
wherea
fewer
bpa
group
patient
rhinoviru
vs
p
primari
endpoint
antibioticday
therapi
significantli
reduc
bpa
group
mean
day
vs
day
p
sever
secondari
endpoint
also
improv
bpa
group
includ
mean
day
therapi
bpa
fire
vs
p
patient
antibiot
discontinu
within
hour
initi
vs
p
fewer
patient
discharg
antibiot
vs
p
differ
rate
antibiot
reiniti
discontinu
vs
p
c
difficil
infect
vs
p
result
found
tabl
adjust
possibl
confound
variabl
show
bpa
associ
fewer
day
therapi
p
antibiot
resist
continu
major
threat
healthcar
commun
despit
advent
expans
rapid
diagnost
test
biomark
effort
still
insuffici
outpac
resist
develop
support
nation
global
effort
rais
awar
signific
issu
knowledg
first
studi
implement
autom
clinician
antimicrobi
stewardship
intervent
leverag
emrdriven
data
like
viral
lrti
defin
neg
pct
posit
viral
respiratori
pcr
result
intervent
highli
effect
reduc
antibiot
prescrib
bpa
decreas
antibioticday
therapi
day
even
adjust
select
variabl
interest
bpa
still
associ
signific
reduct
day
therapi
provid
concern
earli
inappropri
cessat
antibiot
may
pose
risk
failur
increas
need
reiniti
antibiot
bpa
group
initi
stop
alert
led
higher
rate
antibiot
discontinu
within
hour
alert
fire
primari
aim
intervent
quickli
identifi
patient
longer
need
antibiot
lrti
howev
provid
still
feel
compel
continu
therapi
without
activ
oversight
patient
discharg
process
antibiot
often
prescrib
without
regard
appropri
durat
bpa
group
reduct
rate
discharg
prescript
notabl
decreas
postdischarg
antibiot
durat
day
show
impact
beyond
initi
deescal
therapi
note
decreas
postdischarg
durat
therapi
account
primari
outcom
inpatientday
therapi
possibl
extend
benefit
alert
beyond
inpati
stay
previou
studi
shown
inpati
viral
respiratori
infect
manag
vast
potenti
target
intervent
provid
often
continu
antibiot
therapi
even
low
likelihood
bacteri
involv
studi
timbrook
colleagu
found
low
rate
antibiot
discontinu
patient
posit
viral
respiratori
pcr
neg
pct
suggest
viral
etiolog
studi
includ
direct
intervent
author
conclud
clinician
intervent
like
need
affect
antibiot
prescrib
subset
patient
branch
colleagu
implement
random
feasibl
studi
similar
patient
use
respiratori
pcr
pct
test
contrast
previou
studi
employ
intervent
inform
provid
like
viral
infect
though
differ
found
antibiot
use
howev
detect
reduct
antibiot
discharg
prescript
line
find
nearli
note
may
encount
spillov
effect
intervent
studi
group
indirectli
influenc
practic
provid
control
group
studi
abl
avoid
carri
distinct
time
period
overlap
importantli
branch
studi
emphas
need
provid
intervent
leverag
diagnost
test
output
studi
file
colleagu
evalu
respiratori
pcr
result
coupl
pcr
andor
activ
antimicrobi
stewardship
intervent
stewardship
input
compar
avail
pcr
plu
pct
alon
yield
signific
reduct
antibiot
use
though
requir
contact
provid
find
suggest
similar
effort
achiev
without
direct
stewardship
input
allow
shift
effort
highrisk
patient
benefit
respiratori
pcr
test
includ
rapid
turnaround
time
inclus
common
respiratori
viral
pathogen
howev
concern
bacteri
coinfect
limit
provid
willing
quickli
deescal
antibiot
base
sole
pcr
result
concern
unfound
coinfect
rate
may
high
coupl
tempor
relat
pct
valu
within
hour
viral
pcr
result
abl
suggest
provid
subset
patient
unlik
bacteri
coinfect
target
stewardship
alert
enhanc
use
rapid
diagnost
test
determin
infecti
sourc
abil
bpa
affect
provid
decis
make
antibiot
prescrib
play
larg
part
studi
direct
followup
bpa
result
respons
provid
will
stop
antibiot
mani
case
fewer
antibioticday
therapi
rate
antibiot
discontinu
within
hour
alert
fire
provid
may
will
immedi
discontinu
antibiot
case
may
still
earlier
prompt
initi
emr
alert
question
factor
caus
provid
continu
antibiot
rais
followup
analysi
random
trial
branch
colleagu
found
sever
factor
mention
provid
reason
deviat
pct
deescal
protocol
includ
ill
sever
fever
abnorm
complet
blood
count
other
diagnosi
pneumonia
significantli
associ
nonadher
import
distinct
case
virus
abl
caus
radiograph
chang
emr
untap
potenti
enhanc
antimicrobi
stewardship
function
extract
meaning
data
point
leverag
effect
alert
allow
stewardship
principl
activ
time
day
mean
patient
admit
evalu
offhour
site
less
antimicrobi
stewardship
presenc
still
receiv
intervent
suggest
alert
replac
staf
mani
factor
contribut
appropri
evalu
therapi
optim
alert
shown
increas
appropri
antimicrobi
select
studi
highlight
valu
minim
invas
stewardship
allow
emr
assist
identifi
patient
subset
affect
antibiot
use
studi
limit
first
evalu
data
singl
health
system
may
repres
prescrib
institut
second
retrospect
design
allow
minim
bias
comparison
group
studi
attempt
minim
confound
variabl
alway
potenti
unidentifi
effect
one
effect
may
differ
influenza
season
influenza
season
sever
season
evidenc
center
diseas
control
prevent
influenza
data
regress
analysi
still
support
signific
reduct
day
therapi
bpa
began
collect
prospect
data
immedi
alert
launch
decemb
allow
adapt
period
laps
may
skew
true
effect
bpa
anoth
limit
nonconsist
time
bpa
regard
day
therapi
possibl
earlier
fire
bpa
led
toward
earlier
discontinu
antibiot
howev
tempor
relationship
establish
base
data
alon
futur
studi
might
examin
time
relat
outcom
determin
bpa
effect
antibiot
prescrib
limit
studi
includ
lack
stratif
provid
lack
followup
influenc
bacteri
cultur
result
therapi
durat
possibl
certain
provid
inher
open
resist
alert
intent
may
lend
target
feedback
futur
provid
declin
suggest
factor
beyond
pcr
pct
result
may
influenc
treatment
decis
exampl
imag
chang
affect
prescrib
habit
though
imag
alon
differenti
bacteri
vs
viral
ill
anoth
consider
alert
fire
respiratori
pcr
pct
suggest
viral
infect
alert
includ
standalon
pcr
test
influenza
influenzarsv
combin
test
final
issu
bpa
fire
provid
one
inadvert
select
acknowledg
meet
criteria
alert
stop
fire
track
unintent
alert
suppress
realiz
could
affect
success
rate
alert
sever
futur
direct
research
use
similar
approach
first
includ
nonneonat
pediatr
inpati
current
provid
care
popul
health
system
second
character
cost
benefit
implement
target
bpa
intervent
care
receiv
final
may
relationship
time
bpa
antibiot
exposur
area
may
prove
relat
fulli
answer
studi
conclus
studi
show
signific
reduct
antibiot
exposur
patient
like
viral
respiratori
ill
also
prove
wellconstruct
emr
provid
alert
integr
pcr
pct
antibiot
data
target
patient
antibiot
therapi
rapidli
narrow
without
need
direct
antimicrobi
stewardship
oversight
minim
invas
stewardship
practic
easili
replic
institut
repres
step
forward
fight
antibiot
misus
